Cardio-adjacent robots, workflow expansions, and device commercialization: this week mixes a new fund backing medtech, a fresh CE mark, and EU market-surveillance tidings. People on the move DBV Technologies (Germany) Kevin Trapp becomes Chief Commercial Officer to prep European go-to-market. Money flows United Founders (Luxembourg)€80M early-stage fund, cheques up to €1M, targeting AI, hardware, dual-use…
AI pathology and precision health get fresh fuel; MDR CE marks stack up; MHRA drops safety signals and an IDAP tweak—another week of pilot-to-product momentum. People on the move ViCentra (the Netherlands) Ex-Dexcom and Medtronic leaders join to scale Kaleido across Europe; Karen Baxter becomes SVP Sales, Europe; Jay Little becomes VP Strategy & Business…
Valuation isn’t everything but in healthtech, it tells you who’s still scaling Let’s not pretend valuation is the ultimate success metric. But it is a decent proxy for where capital, confidence and commercial traction are flowing. Especially in a market as fragmented and overregulated as European healthcare. The 2025 leaderboard of Europe’s top 10 most…
What’s scaling, who’s paying, and why you should care Let’s start with a question.What do Oura, Sword Health, and Doctolib have in common? If you said “healthtech unicorns” you’re technically right, but that’s not the real answer.The real answer: they’re European, they’re growing like weeds, and most investors or founders still talk about them like…
Funding stacked, boards shuffled, CE marks landed — this week runs on neurotech raises, workflow monitors, and regulator backed AI. People on the move Cardiawave (France): Jonathan Freeman becomes Board Chair as the French non invasive ultrasound outfit gears up for global expansion. CoMind (UK): Taavet Hinrikus, partner at Plural joins the board alongside the…
Workflow AI meets breast imaging and structural heart trials: a week of pragmatic progress across funding, CE marks, and sandboxed regulation. People on the move Avanzanite Pharma names Giovanni Galliano General Manager for Italy to accelerate rare disease launches and market access. AVITA Medical Board Chair Cary Vance becomes Interim CEO as company recalibrates commercialization;…
The €100 Million Bet on Retail Diagnostics Omnichannel in MedTech usually means a half-baked app, an email campaign, or a portal nobody uses. ZEISS changed the script. In March 2025, ZEISS launched its EyeCare Network and quietly took a €10 million stake in Ocumeda, a tele-ophthalmology platform connecting 700 optical stores to 300,000 patients. Retail…
Key Developments, Funding Rounds, Launches, and Regulatory Updates This week in European MedTech and Digital Health has seen steady progress, with notable funding rounds, product launches, regulatory milestones, and leadership changes. Key highlights include the debut of a new ECMO system, a cardiology AI solution achieving its CE mark, and enhanced regulatory cooperation between the…
A deep dive into the EU Commission’s latest findings on AI in healthcare. What MedTech founders and investors need to know in 2025.
Everyone talks about omnichannel. Few do it well. In medtech, digital transformation isn’t optional. It’s survival. Yet for all the noise about AI-driven journeys and seamless customer experiences, even the top players are still building the plane mid-flight. So what can smaller European medtech companies learn from the current leaders? I reviewed the publicly available…